•ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
•Cancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBD
•Variation in the access and use of biologic and targeted synthetic DMARD in juvenile idiopathic arthritis: insights from a national UK survey
•Preparation and anti-inflammatory activity of specific selenium chelated peptides from Antarctic krill
•Patient Identification of the most important outcomes in a gastrointestinal behavioral health program
